{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-019901","form_type":"8-K","ticker":"LFST","cik":"0001845257","company_name":"LifeStance Health Group, Inc.","filed_at":"2023-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.174736+00:00","generated_at":"2026-06-15T07:04:11.667606+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"LifeStance Q1 rev $252.6M (+24% YoY), net loss narrows to $34.2M; raises FY rev guidance","bullets":["Revenue $252.6M (+24% YoY); Center Margin $69.6M (27.6% of revenue, +28% YoY).","Net loss $34.2M vs $62.3M loss; Adj EBITDA $10.1M vs $12.5M (down 19%).","FY 2023 revenue guidance raised to $990M-$1.02B; Center Margin $274-$290M; Adj EBITDA reaffirmed $50-$62M.","Q2 2023 guidance: rev $250-$260M, Center Margin $69-$76M, Adj EBITDA $10-$16M.","Clinicians 5,961 (+19% YoY, net add 330); cash $68.3M, net debt $224.8M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-019901","json":"https://secwatch.observer/filing/0000950170-23-019901.json","markdown":"https://secwatch.observer/filing/0000950170-23-019901.md","text":"https://secwatch.observer/filing/0000950170-23-019901.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845257/000095017023019901/0000950170-23-019901-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845257/000095017023019901/lfst-20230510.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T07:04:11.667606+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c166df461eafc2e121a933c160d46838bfdf442c","claim":"LifeStance Health Group, Inc. reported the first quarter ended March 31, 2023 results: revenue $252.6 million, net income $34.2 million. Guidance raised.","evidence_excerpt":"the first quarter ended March 31, 2023. (All results compared to prior-year comparative period, unless otherwise noted) Q1 2023 Highlights and FY 2023 Outlook • Total revenue of $252.6 million increased $49.5 million or 24% compared to revenue of $203.1 million • Total clinicians of 5,961 up 19%, a sequential net increase of 330 in the first quarter • Net loss of $34.2","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845257/000095017023019901/0000950170-23-019901-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2023"},{"label":"Revenue","value":"$252.6 million"},{"label":"Net income","value":"$34.2 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}